Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Plos Genetics|February 14, 2020
A molecular barcode to inform the geographical origin and transmission dynamics of Plasmodium vivax malariaErnest Diez Benavente, Monica Campos, Jody Phelan, et al.
Malaria Journal|December 19, 2025
Enhancing whole genome DNA amplification of Plasmodium falciparum for advanced molecular surveillance in malaria controlMark K I Tan, Myrela C S de Jesus, Jody E Phelan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 15, 2021
Failure of rapid diagnostic tests in Plasmodium falciparum malaria cases among travelers to the UK and Ireland: Identification and characterisation of the parasitesDebbie Nolder, Lindsay Stewart, Julie Tucker, et al.
Mbio|February 9, 2017
Selective Whole-Genome Amplification Is a Robust Method That Enables Scalable Whole-Genome Sequencing of Plasmodium vivax from Unprocessed Clinical SamplesAnnie N Cowell, Dorothy E Loy, Sesh A Sundararaman, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
<i>pfk13</i>-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United KingdomColin J Sutherland, Paul Lansdell, Mandy Sanders, et al.
Ebiomedicine|May 14, 2020
A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infectionsLynn Grignard, Debbie Nolder, Nuno Sepúlveda, et al.
HIV Medicine|January 29, 2026
Screening for Trypanosoma cruzi infection (Chagas disease) in the Latin American population living with HIV in LondonNatalie Elkheir, Shivani Singh, Birgit Barbini, et al.
Nature Communications|December 31, 2024
Genome sequencing of Plasmodium malariae identifies continental segregation and mutations associated with reduced pyrimethamine susceptibilityAmy Ibrahim, Franziska Mohring, Emilia Manko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2023
Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and LumefantrineDonelly A van Schalkwyk, Sade Pratt, Debbie Nolder, et al.
Mbio|February 25, 2026
Novel <i>Pfk13</i> and <i>Pfubp1</i> genotypes in African <i>Plasmodium falciparum</i> isolates exhibiting reduced susceptibility to the antimalarials artemisinin and lumefantrineSade Pratt, Donelly A van Schalkwyk, Lindsay Stewart, et al.
Pageof 4